(Q35776755)

10 August 2017

1 reference

title

Clinical utilization of atypical antipsychotics in pregnancy and lactation (English)

1 reference

10 August 2017

Salvatore Gentile

1

0 references

language of work or name

English

0 references

publication date

18 May 2004

1 reference

Annals of Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

38

1 reference

10 August 2017

issue

7-8

1 reference

10 August 2017

page(s)

1265-1271

1 reference

Self-reported depression and negative pregnancy outcomes

10 August 2017

cites work

1 reference

Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations

21 January 2018

1 reference

Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants.

21 January 2018

1 reference

The relationship between the Bayley Scales of Infant Development and preschool gross motor and cognitive performance

21 January 2018

1 reference

Olanzapine-exposed pregnancies and lactation: early experience

21 January 2018

1 reference

Healthy outcome under olanzapine treatment in a pregnant woman.

21 January 2018

1 reference

Olanzapine and pregnancy. 2 case reports

21 January 2018

1 reference

21 January 2018

Olanzapine in pregnancy

1 reference

Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk.

21 January 2018

1 reference

Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants

21 January 2018

1 reference

Transfer of risperidone and 9-hydroxyrisperidone into human milk

21 January 2018

1 reference

21 January 2018

Quetiapine and pregnancy

1 reference

Safety of quetiapine during pregnancy

21 January 2018

1 reference

21 January 2018

Clozapine and pregnancy

1 reference

Sexuality, reproduction, and family planning in women with schizophrenia

21 January 2018

1 reference

Women with schizophrenia: pregnancy outcome and infant death among their offspring

21 January 2018

1 reference

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

New-onset diabetes and ketoacidosis with atypical antipsychotics

21 January 2018

1 reference

Glucose intolerance with atypical antipsychotics

21 January 2018

1 reference

Selection of atypical antipsychotics for the management of schizophrenia

21 January 2018

1 reference

A review of the effect of atypical antipsychotics on weight

21 January 2018

1 reference

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications

21 January 2018

1 reference

Long-term risk of malignant neoplasm associated with gestational glucose intolerance

21 January 2018

1 reference

Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants

21 January 2018

1 reference

Neuroleptic withdrawal in schizophrenic patients. A review of the literature

21 January 2018

1 reference

Effects of drug administration in pregnancy on children's school behaviour.

21 January 2018

1 reference

Chlorpromazine levels in plasma and milk of nursing mothers

21 January 2018

1 reference

Clozapine and lorazepam administration in pregnancy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D485

1 reference

10 August 2017

1 reference